OxTalks is Changing
OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Targeting type 1 IFN in immune-mediated inflammatory disease
Building on decades of research, AstraZeneca are starting to unravel complex inflammatory cell signalling pathways and uncover key drivers that cause an imbalance in immune-mediated diseases.
Date:
12 January 2023, 12:00
Venue:
Institute of Developmental and Regenerative Medicine (IDRM) IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford OX3 7TY and Zoom
Speaker:
Dr Hussein Al-Mossawi (AstraZeneca)
Organising department:
Medical Sciences Office
Organisers:
Sheena Lee (MSD Business Partnerships Office),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
sheena.lee@medsci.ox.ac.uk
Host:
Dr Charlotte Bell (University of Oxford)
Part of:
Industry Insight Seminar Series
Booking required?:
Required
Booking url:
https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost:
Free
Audience:
Members of the University of Oxford and the Biotech/Pharma industry
Editor:
Sheena Lee
